Great interest in Senzime at NLSDays 2015, the largest Nordic partnering conference for the Life Science industry

Stockholm, September 2015.

Senzime was selected to present at NLSDays 2015 the leading conference of bringing together the latest and best talents in Life Science. Opportunities for cutting-edge and advanced partnering and networking tools were major outcomes for the company during the Nordic life science days.

(See pictures in attached document)

For further information, please contact:

Lena Söderström, CEO Senzime

Tel: +46-708-16 39 12, e-mail: lena.soderstrom@senzime.com

TO THE EDITORS:

About Senzime

Senzime develops and markets analytical instruments and related disposable products, enabling automated, continuous monitoring of vital substances including glucose (sugar), in biological fluids. Senzime has two platforms for continuously monitoring glucose and lactate – BioSenz in biotech environment and CliniSenz for continuous patient-monitoring. Via microdialysis in tissue or blood Senzime offers a complete system enabling continuous monitoring which is critical to detect post- surgery complications. The company's share is listed on Aktietorget since 2008. www.senzime.com